logo
Plus   Neg
Share
Email

Cambrex Corp. Q4 Profit Tops Estimates; Revenue Up 2.5%

Cambrex Corp. (CBM) reported that its fourth-quarter GAAP EPS from continuing operations increased 4% to $1.20 from $1.15, last year. Adjusted income from continuing operations was $42.4 million or $1.27 per share, compared to $40.8 million or $1.23 per share in the same quarter last year. EBITDA increased to $64.7 million compared to $63.6 million in the same quarter last year. On average, five analysts polled by Thomson Reuters expected the company to report profit per share of $1.12 for the quarter. Analysts' estimates typically exclude special items.

Fourth-quarter net revenue increased 2.5% to $182.3 million compared to $177.9 million in the same quarter last year. Excluding the impact of foreign exchange, net revenue increased 1%. Analysts expected revenue of $184.4 million for the quarter.

The company expects 2018 adjusted net revenue, excluding the impact of foreign currency and change in accounting principle, to be between -2% and 2% compared to 2017 and adjusted EBITDA to be between $150 and $160 million.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Electronics retailer Best Buy Co. Inc. (BBY), Wednesday said it has agreed to buy GreatCall Inc. for $800 million in cash. GreatCall is a provider of connected health and personal emergency response services to the aging population, with more than 900,000 paying subscribers. It offers easy-to-use... Rio Tinto PLC (RIO) is reportedly seeking to divest its Canadian iron-ore business for a possible consideration worth $6 billion. According to Sky News, the Anglo-Australian mining giant has begun courting potential bidders for its $6 billion Canadian iron-ore? operations as it seeks to take advantage... Brewer Constellation Brands Inc. will invest C$5 billion, or $4 billion, in Canadian cannabis company Canopy Growth Corp. as part of an expansion of the two companies' strategic partnership, the companies said Wednesday. Canopy Growth is Canada's largest medical marijuana producer. Shares of Canopy Growth are gaining more than 27 percent in the regular trading.
Follow RTT